Meeting
2019 ASCO Annual Meeting
Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer.
Authors
Wei-Chu Victoria Lai
Memorial Sloan Kettering Cancer Center, New York, NY
Wei-Chu Victoria Lai , Hira Rizvi , Jacklynn V. Egger , Andrew J. Plodkowski , Michelle S. Ginsberg , Mark G. Kris , Amanda Beras , Natasha Rekhtman , John T. Poirier , Matthew David Hellmann , Charles M. Rudin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 8556)
DOI
10.1200/JCO.2019.37.15_suppl.8556
Abstract #
8556
Poster Bd #
312
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinico-pathological and genomic features of NRAS- or HRAS-mutated non-small cell lung cancer (NSCLC) identified in large-scale genomic screening project (LC-SCRUM-Asia).
First Author: Yutaro Tamiya
Poster
2020 ASCO Virtual Scientific Program
Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
First Author: Yutaro Tamiya
Poster
2023 ASCO Annual Meeting
Genomic landscapes to characterize mismatch-repair deficiency (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancers stratified by tumor mutation burden (TMB).
First Author: Jingyuan Wang
Poster
2023 ASCO Annual Meeting
Clinical genomic implications of transcriptional subtypes in pancreatic cancer.
First Author: Harshabad Singh